It is an acetylcholinesterase inhibitor. It can penetrate the blood-brain barrier and counteract non-depolarizing muscle relaxants. It also has a direct excitatory effect on the N2 cholinergic receptors on the motor plate, can improve neuromuscular conduction, and has a certain central cholinergic effect.

It is an acetylcholinesterase inhibitor. It can penetrate the blood-brain barrier and counteract non-depolarizing muscle relaxants. It also has a direct excitatory effect on the N2 cholinergic receptors on the motor plate, can improve neuromuscular conduction, and has a certain central cholinergic effect.

It is an acetylcholinesterase inhibitor. It can penetrate the blood-brain barrier and counteract non-depolarizing muscle relaxants. It also has a direct excitatory effect on the N2 cholinergic receptors on the motor plate, can improve neuromuscular conduction, and has a certain central cholinergic effect.

This product is an anticoagulant that can affect many aspects of the coagulation process. This product accelerates the inactivation of AT-Ⅲ on coagulation factors by combining with antithrombin III (AT-Ⅲ) to form a complex, thereby inhibiting the formation of thrombin prokinase and counteracting the effect of the formed thrombin prokinase. This product can inhibit the adhesion and aggregation of platelets, prevent platelet disintegration and release platelet factor 3 and 5-hydroxytryptamine. The anticoagulant effect of heparin calcium is related to the strong negatively charged sulfate group in its molecule. If the sulfate group is hydrolyzed or neutralized by protamine with a strong positive charge, it will quickly lose its anticoagulant activity. Recent studies have found that heparin calcium also has a variety of non-anticoagulant pharmacological effects such as regulating blood lipids, anti-inflammation, anti-complement, anti-allergy, and immune regulation.

This product is an anticoagulant that can affect many aspects of the coagulation process. This product accelerates the inactivation of AT-Ⅲ on coagulation factors by combining with antithrombin III (AT-Ⅲ) to form a complex, thereby inhibiting the formation of thrombin prokinase and counteracting the effect of the thrombin prokinase that has been formed. This product can inhibit the adhesion and aggregation of platelets, prevent platelet disintegration and release platelet factor 3 and 5-hydroxytryptamine. The anticoagulant effect of heparin calcium is related to the strong negatively charged sulfate group in its molecule. If the sulfate group is hydrolyzed or neutralized by protamine with a strong positive charge, it will quickly lose its anticoagulant activity. Recent studies have found that heparin calcium also has a variety of non-anticoagulant pharmacological effects such as regulating blood lipids, anti-inflammation, anti-complement, anti-allergy, and immune regulation.